Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-07

FDA Approved: MELOXICAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' supplemental application for meloxicam, authorizing the generic NSAID product. This marks regulatory clearance for the M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MELOXICAM (MELOXICAM)

Snippet

SUPPL AP for MELOXICAM (MELOXICAM)